US equities
|
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMZN
$251.40
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
SNDK
$1,704.16
▲+0.00%
TSLA
$378.73
▲+0.00%
SPCX
$171.09
▲+0.00%
NVDA
$238.90
▲+0.00%
MU
$1,063.96
▲+0.00%
AMZN
$251.40
▲+0.00%
META
$741.90
▲+0.00%
AMD
$631.75
▲+0.00%
SNDK
$1,704.16
▲+0.00%
TSLA
$378.73
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NLS Pharmaceutics
Recent news which mentions NLS Pharmaceutics
NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letter
August 28, 2023
Tickers
NLSP
NLSPW
Tags
NLSP
Biotech
Penny Stocks
From
Benzinga
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
October 20, 2021
Tickers
HRMY
JAZZ
NLSP
TAK
Tags
Benzinga
JAZZ
News
From
Benzinga